Hello, sorry for my English, I’m from Russia, long study your forum, you did a great job in Russia still исспользуют for the treatment of Dacarbazine and Zelboraf has not been registered yet, but we will look for ways we have a community of patients with melanoma, we help each other get into clinical research, doctors in Russia they do not offer yourself until you find the information yourself and not попросишься in them. Tell me please, what’s the PD-1, you will write about this new regimen, this is what the drug?
PD1 is a new immunotherapy available in clinical trial from BMS and Merck. It is available in much of Europe but I do not know about Russia. It has a 38% response rate. I can see what is closest to you.